BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181023
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T035106
CREATED:20180716T063217Z
LAST-MODIFIED:20180717T094508Z
UID:16752-1540252800-1540425599@www.pharmajournalist.com
SUMMARY:Healthcare Supply Chain Management Summit 2018
DESCRIPTION:Healthcare Supply Chain Management Summit 2018 will delve on the aspects of gaining greater competency in supply chain management to better manage costs\, weather the storm of impending legislation and identify the tools in place to enable organizations to boost their supply chain procedures by offering a mix of thought provoking and practical sessions while covering a wide range of topics along with a unique industry networking platform. \n \nTo register or download the complete agenda visit https://bit.ly/2mkhSqP \nContact:\nEmail – p.nagvekar@inventicon.in\nPhone – +91 22 66089643
URL:https://www.pharmajournalist.com/event/healthcare-supply-chain-management-summit-2018/
LOCATION:Holiday Inn Mumbai International Airport\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Inventicon Business Intelligence":MAILTO:p.nagvekar@inventicon.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181022
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T035106
CREATED:20180808T114904Z
LAST-MODIFIED:20180808T114904Z
UID:17066-1540166400-1540425599@www.pharmajournalist.com
SUMMARY:Precision CRISPR Drug Discovery and Gene Therapy Congress 2018
DESCRIPTION:Precision CRISPR Congress\, 22-24 October 2018 | London\, UK is a meeting dedicated to supporting pharma and biotech community in realising the drug discovery and gene therapy applications of optimised CRISPR systems. Joining this community will enable you to hear and share the latest CRISPR advances and help accelerate research that will develop solutions to get CRISPR gene therapy into the clinic faster. \n\n\nWith Cornlab recent move to Switzerland\, meet its Principal Investigator Jacob Corn and learn about Gene Repair in Human Hematopoietic Stem Cells.\nDiscover how to detect in vitro & ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett\, University of Copenhagen\nFind out how Barry Rosen\, VP\, AstraZeneca is utilising precise genome engineering to empower drug discovery \n\nSounds interesting? Join us this  October in London and be part of a dedicated community in Europe\, striving to realise the drug discovery & gene therapy applications of optimised CRISPR systems. \nTo learn more about this event\, visit http://bit.ly/2AToGpK
URL:https://www.pharmajournalist.com/event/precision-crispr-drug-discovery-and-gene-therapy-congress-2018/
LOCATION:The Hilton London Olympia\, 380 Kensington High St\, Kensington\, London\, W14 8N\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:tom.hill@crispr-europe.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181022
DTEND;VALUE=DATE:20181025
DTSTAMP:20260515T035106
CREATED:20180803T124056Z
LAST-MODIFIED:20180803T124308Z
UID:17024-1540166400-1540425599@www.pharmajournalist.com
SUMMARY:Gene Therapy for Rare Disorders Europe Summit
DESCRIPTION:2018 is the year gene therapies come into their own. After decades on unfulfilled potential\, this space is gaining tangible momentum\, particularly in addressing the significant unmet need in a range of rare diseases. \n \nGene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market. \nRather than early stage basic science\, this meeting is solely devoted to addressing the latest clinical\, manufacturing\, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Visit the website to see the full agenda\, speaker line-up\, registration costs and more: https://bit.ly/2KoxFys \nClaim a special 10% discount when you quote 9709PJ1 at the checkout. \nContact:\n+44 (0)20 3141 8700\ninfo@hansonwade.com
URL:https://www.pharmajournalist.com/event/gene-therapy-for-rare-disorders-europe-summit/
LOCATION:Novotel London West\, London
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T035106
CREATED:20180511T115222Z
LAST-MODIFIED:20180511T115339Z
UID:15781-1539734400-1539907199@www.pharmajournalist.com
SUMMARY:Orphan Drugs and Rare Diseases Conference
DESCRIPTION:This year’s SMi’s Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies\, pharmaceutical companies\, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors\, policies and issues that will affect the development of orphan drugs globally including commercialization\, policies\, reimbursement\, and pricing. \nKeep up to date with the industry and to learn from expert speaker panel\, bringing you important new case studies and reports on this year’s relevant topics. \n\nHIGHLIGHTS IN 2018: \n\nDiscuss the pricing and reimbursement of orphan drugs\nUnderstand the challenges of patient recruitment and patient-centric research\nHear the MHRA’s perspective on benefit-risk assessment in rare diseases\nExplore the clinical development of orphan drugs for rare disease\nGain insight into potential synergies between regulators and assessors\n\nSPEAKERS INCLUDE: \n\nCarina Schey\, Researcher\, University of Groningen\nSheela Upadhyaya\, Associate Director\, Highly Specialised Technologies\, National Institute for Health and Care Excellence (NICE)\nXavier Ortega\, Project Manager\, Rare Diseases\, Minoryx\nNigel Nicholls\, Director and Country Manager UK/Ireland\, BioMarin Europe Ltd\nYolanda Barbachano\, Senior Statistical Assessor\, MHRA\nMichale Bouskila-Chubb\, Head of Business Development\, Healx\n\nView detailed agenda\, find out who is speaking and book to attend at http://www.orphandrugs.co.uk/phjWL \nTwitter – @SMIpharm & #smiorphandrugs\nLinkedIn – SMi Pharma\nOpt-in – SMi Group value your interest in their events and would like to stay in touch – opt-in via https://www.smi-online.co.uk/opt-in to receive SMi’s updates
URL:https://www.pharmajournalist.com/event/orphan-drugs-and-rare-diseases-conference/
LOCATION:Holiday Inn Kensington Forum\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ldurneva@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T035106
CREATED:20180116T100210Z
LAST-MODIFIED:20180808T084554Z
UID:7746-1539734400-1539907199@www.pharmajournalist.com
SUMMARY:Pharma Cold Chain Summit 2018
DESCRIPTION:ACI’s Pharma Cold Chain Summit 2018 will be taking place on the 17th & 18th October in London\, UK. The two day event will bring together leading experts and stakeholders from across the sector for two days of engaging presentations and interactive discussions. The core challenges and critical issues will be tackled to maintain a robust Cold Chain Management across the global Pharmaceutical Supply Chain. \nJoin us for a balanced programme of practical\, commercial\, case-study-based discussions\, and to meet industry thought leaders and senior-level decision-makers in an informal environment ideal for sharing ideas and making new contacts. \nAgenda: http://bit.ly/2D3csY7
URL:https://www.pharmajournalist.com/event/pharma-cold-chain-summit-2018/
LOCATION:Virtual Conference: Online Access Only
ORGANIZER;CN="Active Communications International%2C Europe":MAILTO:rbaryah@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T035106
CREATED:20170814T012616Z
LAST-MODIFIED:20180427T162111Z
UID:2856-1539734400-1539907199@www.pharmajournalist.com
SUMMARY:European Drug Safety Summit 2018
DESCRIPTION:ACI’s European Drug Safety Summit 2018 will take place in London on 17th & 18th October. The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining drug safety strategies. The event will also discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling\, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall. \nKey Topics Include: \n\nMeeting Safety Requirement: Regulator’s Perspective\nBuilding a Pharmacovigilance Strategy\nEvolving PV Strategies for Tomorrow\nTechnological Advancement in Pharmacovigilance\nClinical Data Management\nThe Role of Big Data and Social Media in PV\nEnsure Drug Safety & Risk Minimisation Measures\nLatest Development & Innovation Approach for Effective Signal Management\nDevelopment of Qualified Personal Responsible for Pharmacovigilance (QPPV)\nPharmacovigilance for Advanced Therapies\n\nWho Will Attend? \nAttendees will be drawn primarily from pharmaceutical\, biotechnology and contract research organisations and include VPs\, Directors and Managers/Scientists working in Drug Safety\, Pharmacovigilance\, Epidemiology\, Clinical Research and Development\, Clinical Trial Management\, Pharmacology\, Regulatory Affairs and Compliance\, Strategy and Business Development\, Risk Management\, QPPV.
URL:https://www.pharmajournalist.com/event/european-drug-safety-summit-2018/
LOCATION:London\, UK
ORGANIZER;CN="ACI":MAILTO:cwilliams@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181018
DTSTAMP:20260515T035106
CREATED:20180820T083550Z
LAST-MODIFIED:20180820T083550Z
UID:17281-1539648000-1539820799@www.pharmajournalist.com
SUMMARY:Outsourcing Clinical Trials Pacific Northwest 2018
DESCRIPTION:The global OCT series will be returning once again to the Pacific Northwest to celebrate the best in clinical trial management. In 2018 we’ll be visiting Vancouver and will be building on the success of our Seattle 2017 launch. \n \nWe’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes\, panel debates and roundtables on the biggest issues of the day. \nWe’ll be showcasing best in class local trial sponsors and you can expect a series of keynotes\, panel debates\, workshops and roundtables on the biggest issues of the day. \nThe 2018 agenda highlights include a Keynote session exploring how to underpin and sustain your competitive advantage in the PNW region; an interactive panel discussion comparing experiences with local vs international trials; and a regulatory update to pinpoint what you should be considering when it comes to clinical regulatory aspects. \nJoin us in Vancouver on October 16th & 17th to discuss\, deliberate and debate the latest operational and outsourcing challenges in conducting your clinical trials. \nBook your place now to avoid disappointment! \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/octpnw
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-pacific-northwest-2018/
LOCATION:Vancouver
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181018
DTSTAMP:20260515T035106
CREATED:20180628T105002Z
LAST-MODIFIED:20180628T110758Z
UID:16509-1539648000-1539820799@www.pharmajournalist.com
SUMMARY:LogiMed 2018
DESCRIPTION:LogiMed 2018 | Date: 16 – 17 October\, 2018 | Venue: Novotel Amsterdam City Amsterdam \nLogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark\, interact\, network and develop professionally. \n \nDownload the agenda to find out exactly who is speaking\, what the hottest topics are and how LogiMed can benefit you. LogiMed 2018 will bring together 150 Medical Device Supply Chain Professionals and 45 expert speakers over 2 value packed days. \nMixing interactive presentations from Global Heads of Supply Chain with practical\, interactive ‘how to’ case studies from proven procurement experts\, LogiMed helps Medical Device Manufacturers to transform their supply chain. \nAs a proud sponsor of the event\, we are pleased to offer you an exclusive 15% discount off the full price to attend\, using our code: LG18PJ \nTo learn more about LogiMed 2018\, and to register online\, visit http://bit.ly/2Mf2l7v
URL:https://www.pharmajournalist.com/event/logimed-2018/
LOCATION:Novotel Amsterdam City\, Amsterdam\, Netherlands
ORGANIZER;CN="Worldwide Business Research":MAILTO:Helmi.Pikarinen@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181019
DTSTAMP:20260515T035106
CREATED:20171106T104802Z
LAST-MODIFIED:20180802T154835Z
UID:3828-1539648000-1539907199@www.pharmajournalist.com
SUMMARY:12th Digital Pharma East
DESCRIPTION:Join more than 800 attendees for the largest event focused exclusively on digital marketing for the life sciences — Digital Pharma East. Our faculty of more than 120 senior-level professionals share their lessons learned and actionable insights to help you leverage innovation to provide an optimal customer experience and improve health outcomes. \n  \nTo learn more about this event\, and to register online\, visit digitalpharmaseries.com/east
URL:https://www.pharmajournalist.com/event/12th-digital-pharma-east/
LOCATION:Pennsylvania Convention Center\, 1101 Arch Street\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181010
DTEND;VALUE=DATE:20181013
DTSTAMP:20260515T035106
CREATED:20180627T065536Z
LAST-MODIFIED:20180627T070348Z
UID:16489-1539129600-1539388799@www.pharmajournalist.com
SUMMARY:BioNetwork
DESCRIPTION:BioNetwork\n\nOctober 10 – 12\, 2018\nThe Ritz-Carlton\, Laguna Niguel\, CA. One\, Ritz Carlton Dr\, Dana Point\, CA 92629 \n\nBioNetwork is the essential deal-making event for business development executives in pharmaceutical and biotechnology. You’ll nurture strategic partnerships in our beautiful\, intimate venue. Pharma/Big Biotechs – register with code BIO18PHARMA and get 15% off your pass! \nTo learn more about this event\, and to register online\, visit bionetwork.wbresearch.com
URL:https://www.pharmajournalist.com/event/bionetwork/
LOCATION:The Ritz-Carlton\, Laguna Niguel\, One Ritz Carlton Drive\, Dana Point\, CA\, 92629\, United States
ORGANIZER;CN="Worldwide Business Research":MAILTO:bionetwork@wbresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181010
DTEND;VALUE=DATE:20181012
DTSTAMP:20260515T035106
CREATED:20180507T072343Z
LAST-MODIFIED:20180507T090028Z
UID:15692-1539129600-1539302399@www.pharmajournalist.com
SUMMARY:Cell & Gene Therapy 2018
DESCRIPTION:SMi introduces their inaugural event on Cell & Gene Therapy which takes place between the 10th and 11th October 2018\, with an interactive pre-conference workshop on the 9th October. \n\nCell and gene therapeutics have revolutionised modern medicine and mark a new generation in biomedical and agricultural sciences. The latest developments in cell and gene therapies and specifically in gene editing\, technologies present unlimited research opportunities ranging from novel therapeutic tools to a potential revolution in the field of drug discovery. \nThis year’s event will be led by scientists and clinicians researching\, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology\, stem cell manipulation and DNA repair techniques. The conference will cover all aspects of the subject\, including biomedical science principles\, molecular basis of disease\, current and developing technologies and clinical applications. \nThe conference will be inviting speakers from global pharmaceutical organisations\, leading biotech companies and internationally renowned academic institutions Expect over 16 presentations and case studies focused on the key aspects of GMP\, bioprocessing\, regulatory frameworks and new therapeutic developments in in the field of cell and gene. \nHear from our expert speaker panel\, bringing you interesting case studies and detailed presentations on new and industry relevant topics\, including: \n\nCell Therapy Research\nManufacturing Innovation\nGlobal Medical Affairs\nRegulatory Updates\nGMP and Quality Control\nCell and Tissue Therapies (CART therapies\, stem cells\, cord blood\, preclinical and clinical developments)\nRegenerative Medicine\nAdvanced Therapy Production\nGene Therapy Development\nClinical Platform Development\nManufacturing\nR&D of Cell and Gene Therapies\n\nCHAIR FOR 2018: \n\nPamela Tranter\, Head of Translational Research Group\, UCL\n\nKEY SPEAKERS INCLUDE: \n\nJanet Glassford\, Senior Quality Assessor (Biologicals)\, MHRA\nGiuseppe Ronzitti\, Cell and Gene Therapy Specialist\, Genethon\nKei Kishimoto\, Chief Scientific Officer\, Selecta Biosciences\nShailesh Gupta\, Senior Scientist\, AstraZeneca\nPeggy Sotiropoulou\, R&D Manager\, Research and Development\, Celyad\nJulie Kerby\, Head of Manufacturing Development\, Cell and Gene Therapy Catapult\nLior Raviv\, Vice President\, Development\, Pluristem\nDiego Aridgo\, R&D Rare Disease Unit Head\, Chiesi\nMehdi Gasmi\, Chief Science and Technology Officer\, Adverum Biotech\nEmanuela Cuomo\, Associate Director\, Discovery Sciences\, Cellular Biology Team\, AstraZeneca\nYen Choo\, Founder and Executive Chairman\, Plasticell\nIan McKay\, Innovation Lead Advanced Therapies\, Innovate UK\n\n2018 FEATURED HIGHLIGHTS: \n\nDiscuss the challenges of accessing patients with commercial ATMPs\nUnderstand the advantages of a risk-based approach to cell and gene therapy manufacturing\nHear the MHRA’s perspective of UK and EU regulatory affairs regarding ATMPs\nExplore the unique applications of the CRISPR/Cas9 system for drug development at AstraZeneca\nGain insight into GMP Manufacture of plasmid DNA at the NHSBT\n\nView the full agenda online: www.cellandgeneconference.com/pj \nEARLY-BIRD RATES: \n\nREGISTER BY 31ST MAY AND SAVE £400\nREGISTER BY 29TH JUNE AND SAVE £300\nREGISTER BY 31ST AUGUST AND SAVE £200
URL:https://www.pharmajournalist.com/event/cell-gene-therapy-2018/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181009
DTEND;VALUE=DATE:20181011
DTSTAMP:20260515T035107
CREATED:20180717T104113Z
LAST-MODIFIED:20180717T104113Z
UID:16780-1539043200-1539215999@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials DACH 2018
DESCRIPTION:We are pleased to announce that the OCT series is extending to Switzerland 2018 to bring innovative and solutions focused content to the DACH biopharmaceutical market. Spinning off from the flagship OCT Europe event this intimate audience of local players allows for focused\, lucrative learning and networking on site. \n \nThrough in-depth research conducted with local biopharma companies\, this event will deliver insight\, debate\, discussion\, presentation and opinion on high priority outsourcing\, operations and technology-based themes within the clinical trials space locally. \nKey Agenda Highlights 2018\n1) Building collaborations with external providers to guarantee the best delivery through innovation. (Gisele Tavares\, Procurement – Global Head Alliance Management and Internal Business Partner at Roche) \n2) Onstage Interview: Working to foster a reputation in clinical development to partner with large solution providers for trusted timelines and high-quality deliverables – (Dirk Weber\, Chief Medical Officer at Cellestia Biotech AG/Aurealis Pharma AG) \n3) Considerations in observational research – the importance of long-term partnerships – (Pamela Bacon\, Head of Medical Affairs Communications and Operations\, Worldwide Markets at Celgene)  \nWhy must you attend? \nOCTDACH brings recognised experts specifically in the DACH region to discuss\, collaborate and network with a variety of key service providers as well as other biopharmaceuticals from innovative and collaborative ideas to help overcome challenges. \nThis event will deliver insights\, debates\, discussions\, presentations and opinion on high priority outsourcing\, operations and technology-based themes within the clinical trial space locally. \nTo learn more about this event\, and to register online\, visit http://bit.ly/OCTDASH2018 \nContact: \nPhone – +44 (0) 207 936 6521\nEmail – brijesh.patel@arena-international.com
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-dach-2018/
LOCATION:Radisson Blu\, Zurich Airport\, Rondellstrasse\, 8058 Kloten\, CH-8058
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181008
DTEND;VALUE=DATE:20181010
DTSTAMP:20260515T035107
CREATED:20180411T074155Z
LAST-MODIFIED:20180522T120949Z
UID:14359-1538956800-1539129599@www.pharmajournalist.com
SUMMARY:Global Biobanking Congress
DESCRIPTION:Designed to attract industry leaders and academics\, this conference will look at ways to optimize biosample management and consider the future of emerging technologies such as mobile biobanking\, digital & cloud-based sample management and automated storage & retrieval systems. Key topics will also include data protection\, data sharing\, and the importance of ethical and regulatory considerations for maximising clinical impact. The Congress will provide a forum to network\, learn\, and engage with experts and representatives from pharmaceutical companies\, leading institutions\, and recognised biobanks worldwide.
URL:https://www.pharmajournalist.com/event/global-biobanking-congress/
LOCATION:TBC\, London\, United Kingdom\, United Kingdom
ORGANIZER;CN="Global Engage":MAILTO:info@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181001
DTEND;VALUE=DATE:20181003
DTSTAMP:20260515T035107
CREATED:20180530T112357Z
LAST-MODIFIED:20180530T112357Z
UID:16023-1538352000-1538524799@www.pharmajournalist.com
SUMMARY:3rd Partnerships in Biocontrol\, Biostimulants\, & Microbiome: USA
DESCRIPTION:Attracting experts working in all areas of plant science\, the conference\, held on October 1-2\, 2018 in Philadelphia\, will examine the latest developments in the technologies and techniques being used for developing biopesticides and biostimulants research\, EU regulation\, as well as the future of the industry. \nURL: http://www.global-engage.com/event/agricultural-biologicals/ \nCo-Located with the 6th Plant Genomics & Gene Editing Congress: USA
URL:https://www.pharmajournalist.com/event/3rd-partnerships-in-biocontrol-biostimulants-microbiome-usa/
LOCATION:Philadelphia\, USA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181001
DTEND;VALUE=DATE:20181003
DTSTAMP:20260515T035107
CREATED:20180530T111706Z
LAST-MODIFIED:20180530T112721Z
UID:16014-1538352000-1538524799@www.pharmajournalist.com
SUMMARY:6th Plant Genomics & Gene Editing Congress: USA
DESCRIPTION:Attracting scientists working in all areas of plant research\, the conference\, held on October 1-2 2018\, will examine the latest strategies\, technologies and research techniques utilizing NGS\, ‘omic’ technologies\, phenotyping\, epigenetics\, bioinformatics\, regulation and data analysis to further plant research. \nTo find out more information\, please visit our website:\nhttp://www.global-engage.com/event/plant-genomics-usa/ \nOr email us at info@globalengage.co.uk \nCo-Located with the 3rd Partnerships in Biocontrol\, Biostimulants\, & Microbiome USA
URL:https://www.pharmajournalist.com/event/6th-plant-genomics-gene-editing-congress-usa/
LOCATION:The Logan Philadelphia\, One Logan Square\, Philadelphia\, PA\, 19103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180926
DTEND;VALUE=DATE:20180928
DTSTAMP:20260515T035107
CREATED:20180501T144153Z
LAST-MODIFIED:20180501T144153Z
UID:15510-1537920000-1538092799@www.pharmajournalist.com
SUMMARY:Immuno-Oncology
DESCRIPTION:Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. \nSMi’s Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry\, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress. \n\nAt the SMi’s Immuno-Oncology Conference participants will get: \nAgenda-  Over 15 engaging presentations\, case studies\, keynote addresses\, including: \n\nTargeting immune checkpoints with Humabody VH therapeutics\nRecent advances in providing durable disease control with Keytruda as an anti-cancer therapy\nTumour mutation burden and the potential of its use as an indication of treatment choice\nUnwanted immunogenicity and functionality testing of immuno-oncology drugs\nNew techniques\, such as the emerging applications of liquid biopsies\, in Immuno-Oncology\n\nSpeakers–Over 15 leading experts in Immuno-Oncology field\, including: \n\nJames Legg\, Vice President R&D\, Crescendo Biologics\nAndrew Exley\, Medical Assessor\, MHRA\nHarry Smith\, Medical Scientist\, Gilead Sciences\nGrace Macaulay\, Global Safety Physician Patient Safety Oncology\, MedImmune\nDavid Giljohan\, CEO\, Exicure\nKandeepan Ganeshalingam\, Executive Director\, Oncology Therapeutic Area Head\, European Clinical Development\, MSD\nRochana Wickramasinghe\, Director of Oncology Evaluation\, AstraZeneca\n\nWorkshops – Carefully selected topics for further on-sight training. 2 pre-conference workshops (25 September) to provide in-depth knowledge on specific topics: \n\nStrategic Competitive Intelligence in the Immuno-Oncology space – hosted by LucidQuest Ventures\nCould the Microbiome boost Cancer Immuno-Therapy – hosted by ImmuneBiotech and Lund University\n\nNetworking – it is at the forefront of SMi events. 5+ hours of pure networking guaranteed. Follow event updates to be in the know about who will be joining the conversation. \nTo View detailed information about event programme\, speaker line-up and workshop agenda visit http://www.immuno-oncology-conference.com/phjWL \nTwitter – @SMIpharm & #immunooncologysmi \nLinkedIn – SMi Pharma
URL:https://www.pharmajournalist.com/event/immuno-oncology/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:durneva@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180926
DTEND;VALUE=DATE:20180928
DTSTAMP:20260515T035107
CREATED:20180411T161558Z
LAST-MODIFIED:20180411T161558Z
UID:14392-1537920000-1538092799@www.pharmajournalist.com
SUMMARY:Biosimilars & Biobetters 2018
DESCRIPTION:SMi presents the 9th Annual Conference on Biosimilars & Biobetters\nForecasting the next wave of biosimilars to ensure optimal market commercialisation \nThe SMi Group are thrilled to present the 9th annual conference on Biosimilars & Biobetters\, taking place on 26th & 27th September in Central London\, UK. Following the success of our previous events in both London and the US\, Biosimilars and Biobetters UK 2018 will deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market. \n\nAfter over a decade\, the biosimilars industry is finally reaching a stage where key stakeholders understand and accept biosimilars. This is reflected in more tolerant legislation and an increased uptake of biosimilars across the globe. \nWe are now entering a very exciting time\, for over the next few years several originator patents are expiring\, and we will see the next few waves of biosimilars enter the market. Will the biosimilar be a successful contender and spark a competitive environment or the originator dominate? Have we done enough to convince the payer\, prescriber and patient to switch? \nJoin us to hear experiences of key opinion leaders and evaluate market access\, opportunities and commercialisation strategies with industry-thought experts. \nThis event is CPD accredited. \n#SMiBiosimilars \nWHO SHOULD ATTEND \nChief Executives\, Vice Presidents\, Executive Directors\, Directors\, Heads\, Managers and Specialists from the following\, but not limited to\, sectors should attend: \n\nBiosimilars / Biologics\nBiopharmaceuticals\nResearch and Development\nLegal Affairs\nIntellectual Property\nRegulatory Compliance\nQuality affairs and control\nPharmacovigilance\, Drug Safety and Risk Management\nBusiness Development\nCommercialisation\nMarketing and sales\n\nEARLY BIRD-RATES \n\nBOOK BY 30TH APRIL AND SAVE £400\nBOOK BY 31ST MAY AND SAVE £200\nBOOK BY 29TH JUNE AND SAVE £100\n\nTo learn more about this event\, and to register online\, visit http://www.biosimilars-europe.com/pharmajournalistWL
URL:https://www.pharmajournalist.com/event/biosimilars-biobetters-2018/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180925
DTEND;VALUE=DATE:20180928
DTSTAMP:20260515T035107
CREATED:20180808T115442Z
LAST-MODIFIED:20180808T115700Z
UID:17070-1537833600-1538092799@www.pharmajournalist.com
SUMMARY:IMPACCT: RWE - Real-World Evidence Conference 2018
DESCRIPTION:IMPACCT: RWE is taking place in Boston\, MA on September 25-27 2018\, and is the only meeting dedicated to supporting drug developers in making real-world evidence-based decisions\, from clinical development to commercialization of their products. \n\nAttend this meeting and benefit from: \n\nCase-Study Led Content\nWe know the value of case-study led discussions. That’s why at the IMPACCT:RWE Summit we’ve tailor-made an agenda that contains over eighteen case studies around how real-world evidence is currently being applied across the drug development continuum to support decision-making in clinical development\, drug marketing and commercialization\, and how you can define and develop a comprehensive evidence generation plan that supports activities from clinical to commercial. You will have a chance to discuss with peers and learn from thought leaders in the industry such as Lundbeck\, Biogen\, BMS\, Amgen\, GSK\, Pfizer and more.\nMeet and Network with Industry Pioneers\nWith a room full of senior drug development and commercialization professionals striving to effectively leverage real-world evidence to benefit patients\, this summit is your chance to meet like-minded industry peers to shape the future of RWE together.\nPre-Conference Workshop Session\nIn a highly engaging and interactive discussion\, you will learn decision science basics\, including implementation examples. The group will also explore opportunities and strategies for RWE to leverage decision science as a vehicle to achieve greater value by informing and helping to change drug development and commercial decision making within your organization.\n\nTo learn more about this event\, visit http://bit.ly/2OP3kMW
URL:https://www.pharmajournalist.com/event/impacct-rwe-real-world-evidence-conference-2018/
LOCATION:Hilton Boston/Woburn\, 2 Forbes Rd\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:mafalda.andrade@impacct-rwe.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180920
DTEND;VALUE=DATE:20180922
DTSTAMP:20260515T035107
CREATED:20180810T153223Z
LAST-MODIFIED:20180810T153223Z
UID:17147-1537401600-1537574399@www.pharmajournalist.com
SUMMARY:Deep Learning in Healthcare Summit
DESCRIPTION:The Deep Learning in Healthcare Summit is returning for the 3rd annual event in London! Deep Learning is the most advanced subset of AI and is of interest to many leading players in the AI world. AI is set to revolutionise healthcare and deep learning technology is enhancing all aspects of the industry such as diagnostics\, patient care\, surgery\, health and well being\, and pharmaceuticals. The benefits could be life-changing. \n \nHear from industry leaders\, academics\, researchers and innovative startups working to advance deep learning technology in Healthcare. Focusing on topics such as medical imaging\, speech recognition\, diagnostics\, pattern recognition and how these are applied within Healthcare. The summit is a great way to discover the latest insights\, evaluate your position within the field and how the impacts can affect yourself and your work and network with people working in the field to create opportunities to collaborate and broaden your knowledge. \nTo learn more about this event\, visit https://bit.ly/2M71OZ8
URL:https://www.pharmajournalist.com/event/deep-learning-in-healthcare-summit/
LOCATION:155 Bishopsgate\, Liverpool Street\, London\, EC2M 3YD\, United Kingdom
ORGANIZER;CN="RE%E2%80%A2WORK":MAILTO:hello@re-work.co
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180919
DTEND;VALUE=DATE:20180920
DTSTAMP:20260515T035107
CREATED:20180723T065910Z
LAST-MODIFIED:20180723T070128Z
UID:16855-1537315200-1537401599@www.pharmajournalist.com
SUMMARY:Pharma Packaging\, Labelling\, Serialization\, Track and Trace 2018
DESCRIPTION:The Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2018 conference organized by Virtue Insight will provide a great opportunity for learning and networking. The goal of the conference is to uncover the insights of the most emerging best practices and industry expertise in the field of packaging & labelling in the pharmaceutical sector. This conference attracts packaging\, labelling\, serialisation\, track and trace and artwork experts from across big and small pharma\, who come together to share case studies\, discuss the current challenges and find solutions. \nThis year we will be exploring topics\, which affect both commercial labelling and packaging teams across small\, medium and large pharma. We will have a co-presentation looking at the industries end-toend labelling strategy to ensure companies are inspection ready while harnessing branding as a storytelling tool to remain relevant to your consumers\, old and new. Coupled with this we aim to show ways through which the operational challenges of serialization can be overcome and improved to ensure you are meeting compliance standards. \nKEY SPEAKERS: \n\nOMPRAKASH S. SADHWANI\, Joint Commissioner (Nashik Division)\, Food and Drugs Administration (M.S.)\nAMIT KALE\, Associate Vice President – Packaging and Automation\, Reliance\nTAPAN PATI\, Director & Senior Legal Counsel\, South Asia\, Johnson & Johnson\nVISHWANATH MALKAR\, President Quality Management\, ASolution Pharmaceuticals\nCHANDRA SEKHAR\, Vice President Quality\, Reliance Life Sciences\nSAMIR VASAVADA\, Associate Director – MS&T and PLM\, Abbott\nLOKESH SHARMA\, Director-Supply Chain\, Eisai Pharmaceuticals\nSHALIGRAM RANE\, Site Quality Head\, Biotech Division\, Lupin\nNARESH TONDARE\, Head– India and Nepal Regulatory Affairs\, Glenmark Pharmaceuticals\nMILIND ANTANI\, Partner In-Charge – Pharma LifeSciences\, Nishith Desai Associates\nALAP GANDHI\, Head\, Medical Affairs\, Glaxo Smith Kline (GSK)\nR.SALUNKHE\, Former Assistant commissioner\, FDA Maharashtra\nRANJIT BARSHIKAR\, QbD / CGMP Consulting\, Member Editorial Board Journal of Generic Medicines\, England\nVINEET CHAUDHARY\, General Counsel\, Wockhardt\nVIRENDRA SINGH\, Manager Packaging Development\, Stelis\n\nKEY THEMES DISCUSSED: \n\nEnd-to-End optimization: solutions and challenges\nBest practice guide to gain advantage on your product packaging and labelling\nEfficient serialisation strategies: Business Case\, Road map and basic decisions\nDiscuss your serialization\, track and trace\, and brand protection programs with peers at this interactive session\nRecognize industry best activity solutions to better your labelling analyse activity and distinguish potential errors\nCurrent cost-effective packaging methods and innovations for pharmaceutical packaging\nRethinking Supply Chain Strategy – Securing it\nSmart Packaging and Labelling – Warehouse & Logistics – Lessons to learn\nDeveloping an efficient and smart packaging strategy to adapt to new challenges\nDeveloping products and packaging while focusing on patient/consumer needs and demands\nImproving consumer experience while researching directions in pharmaceutical packaging\nMaking packaging to better the patient lives – enhancing revenue by remaining the first choice\nChallenges and solutions while temperature controlled packaging\nMaking sure you are top of the changing labelling landscape by figuring your inspection forwardness strategy\nHow can companies and government work closely together and its importance?\nGlobal guideline alterations without compromising your present timelines to set up an internal tracking and reporting systems\nSetting up best practice to avoid counterfeits getting into your drug supply chain\nGlobal regulatory end-to-end tracking process and its critical functionality\nInvestigating the wider regulatory surroundings to insure your packaging\, labeling\, serialisation\, track and trace schemes are regulatory compliant and inspection ready\nChallenges of implementing the falsified medicines directives in India\nBe part of a major networking opportunity\n\nWHO SHOULD ATTEND: \nCEO’s\, Senior Vice Presidents\, Vice Presidents\, Senior Executives\, Heads\, Directors\, Managers\, Advisors\, Strategists and Analysts of: \nPharmaceutical companies\, Biotech companies\, Artwork\, Serialisation\, Track and Trace – Solution Providers\, Brand Protection\, Enforcement\, security\, Integrity and Management companies\, Design Regulatory Affairs\, Quality\, Product Development Materials Handling/Management\, Product Information Operations\, Licensing\, Marketing and Sales Patient Compliance\, Materials\, Warehouse\, Engineering Lean Production\, Procurement\, Purchase/Facilities Manufacturing Technology\, Supply chain and Logistics\, Government\, Payers\, Insurance companies. \nCONFERENCE REGISTERATION: \nIn order to register you can simply let us know your interests through Email: kavitha@virtueinsight.co.in  or Mobile- +91 8270495331 or TEL: +91 44 24762472 \n\nEarly Bird Discount Price (Till 2nd August 2018) – INR 6\,000 + GST(18%) per delegate\nStandard Price (3rd August 2018 Onwards) – 1 or 2 delegate – INR 7\,000 + GST(18%) per delegate\nGroup Discounts – 3 or 4 delegates – INR 6\,500 + GST(18%) per delegate\nGroup Discounts – For 5 & above delegates – INR 6\,000 + GST(18%) per delegate\nSpot Registration on the day of the conference – INR 8\,000 + GST(18%) per delegate\nConference Sponsor\, Exhibition Stall (Booth) and a paid Speaker slots are also available\n\nGet more from the event\, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time\, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/pharma-packaging-labelling-serialization-track-and-trace-2018/
LOCATION:Kohinoor Continental Hotel\, Andheri Kurla Road\, Andheri ( E )\, Mumbai 400059 – India\, Mumbai\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180919
DTEND;VALUE=DATE:20180921
DTSTAMP:20260515T035107
CREATED:20180419T065706Z
LAST-MODIFIED:20180419T065906Z
UID:15013-1537315200-1537487999@www.pharmajournalist.com
SUMMARY:3rd European Prefilled Syringes Summit
DESCRIPTION:After the two successful ACI’s European Prefilled Syringes Summit\, we are pleased to announce the next edition which shall take place on the 19th & 20th September in Berlin\, Germany. \n\nThe event will explore the advancements in regulatory guidelines\, product development\, manufacturing processes\, risk mitigation \, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology\, connectivity\, speed to market\, and next generation syringes. \nThere are several elements that pose a severe challenge to the growth of the global prefilled syringes market\, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables\, the potential risk of interaction between prefilled syringes and drugs\, and needle stick prevention. \nKey Topics Include:  \n\nMarket Insights –what is happening in the PFS & Devices Market\nRegulation of the Manufacture and Control\nTechnical Advances in mechanisms\, application systems. And devices\nImproving quality\, connectivity\, and cost control for combination products\nNext generation materials & design of PFS\nBalancing biopharmaceutical product portfolio for continual product innovation & Creating a lower-risk product development strategy\nSmart devices: their emerging role in auto-injector systems & driving innovation\nShift from glasses pre-filled syringes to plastic prefilled syringes \n\n£240subscriber’s discount available on the registration fee.  \nTo receive the agenda or for the priority registration\, please contact\nMohammad Ahsan on +44 (0)20 3141 0606 or email:mahsan@acieu.net
URL:https://www.pharmajournalist.com/event/3rd-european-prefilled-syringes-summit/
LOCATION:Berlin\, Germany
ORGANIZER;CN="Active Communications Europe Ltd (ACI)":MAILTO:mahsan@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180918
DTEND;VALUE=DATE:20180920
DTSTAMP:20260515T035107
CREATED:20180820T080354Z
LAST-MODIFIED:20180820T080354Z
UID:17260-1537228800-1537401599@www.pharmajournalist.com
SUMMARY:Pharma Packaging\, Automation\, Labelling & Yield
DESCRIPTION:The Pharma PLAY is the meeting place for the worldwide packaging\, labelling and regulatory community. The exchange format has been specially curated to enable you to get the latest innovations\, advancements\, and insight in the most innovative\, interactive and inspiring way. Covering all the key topics that are at the heart of packaging and labelling\, the conference will provide a total and complete insight into the latest developments in the space of pharma packaging. \n \nTo learn more about this event\, and to register online\, visit http://pharmaplay.encom-global.com
URL:https://www.pharmajournalist.com/event/pharma-packaging-automation-labelling-yield/
LOCATION:Plaza Frankfurt Congress Hotel\, Frankfurt Am Main\, Germany
ORGANIZER;CN="Engaged Communications":MAILTO:savio.soares@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180918
DTEND;VALUE=DATE:20180920
DTSTAMP:20260515T035107
CREATED:20180820T075915Z
LAST-MODIFIED:20180820T075915Z
UID:17256-1537228800-1537401599@www.pharmajournalist.com
SUMMARY:Pharma Serialization Exchange
DESCRIPTION:The Pharma Serialization Exchange is the meeting place for the worldwide serialization\, IT\, trace and trace and supply chain community. The exchange format has been specially curated to enable you to get the latest innovations\, advancements\, and insight in the most innovative\, interactive and inspiring way. Covering all the key topics that are at the heart of serialization\, the conference will provide a total and complete insight into the latest developments in the space of pharma serialization. \n \nTo learn more about this event\, and to register online\, visit http://pse.encom-global.com
URL:https://www.pharmajournalist.com/event/pharma-serialization-exchange/
LOCATION:Plaza Frankfurt Congress Hotel\, Frankfurt Am Main\, Germany
ORGANIZER;CN="Engaged Communications":MAILTO:savio.soares@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180913
DTEND;VALUE=DATE:20180915
DTSTAMP:20260515T035107
CREATED:20180514T103353Z
LAST-MODIFIED:20180626T062559Z
UID:15804-1536796800-1536969599@www.pharmajournalist.com
SUMMARY:The 5th Global Precision Medicine & Biomarkers Leader’s Summit
DESCRIPTION:EXAMINING GROUNDBREAKING BIOMARKER\, COMPANION DIAGNOSTIC\, IMMUNO-ONCOLOGY\, GENOMIC & BIG DATA AND AI RESEARCH TO FACILITATE THE DEVELOPMENT OF IMPACTFUL PERSONALIZED TREATMENTS FOR PATIENTS \nFollowing the very successful 2017 meeting\, Global Engage are beginning work on the 5th Global Precision Medicine & Biomarkers Leaders Summit which will take place on September 13-14\, 2018 in Munich\, Germany. The 2018 summit will provide a forum to network\, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide. \nAttending this Summit will provide you with the opportunity to mix and interact with experts working in all facets of Precision Medicine through the individual\, panel and roundtable discussions on offer. It is a Summit not to be missed.
URL:https://www.pharmajournalist.com/event/the-5th-global-precision-medicine-biomarkers-leaders-summit/
LOCATION:Holiday Inn Munich
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180913
DTEND;VALUE=DATE:20180915
DTSTAMP:20260515T035107
CREATED:20180503T161344Z
LAST-MODIFIED:20180503T161537Z
UID:15600-1536796800-1536969599@www.pharmajournalist.com
SUMMARY:The 4Bio Summit: USA
DESCRIPTION:Global Engage is pleased to announce the 2018 4BIO Summit comprised of the 4th qPCR and Digital PCR Congress USA and the 3rdMicrofluidics Congress USA. The event will be held on the 13th-14th September 2018 in San Francisco\, USA and is part of our successful life science technologies series with a sister event in Europe in December. \nThe conference will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions\, poster presentation sessions\, expert led case study presentations\, panel discussions\, and interactive Q&A sessions from a 50 + speaker faculty. \nTo learn more about this event\, and to register online\, visit http://www.global-engage.com/event/4bio-usa
URL:https://www.pharmajournalist.com/event/the-4bio-summit-usa/
LOCATION:The Holiday Inn San Francisco – Golden Gateway\, USA
ORGANIZER;CN="Global Engage":MAILTO:anna@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180911
DTEND;VALUE=DATE:20180913
DTSTAMP:20260515T035107
CREATED:20180307T145454Z
LAST-MODIFIED:20180307T145454Z
UID:11600-1536624000-1536796799@www.pharmajournalist.com
SUMMARY:Extractables and Leachables China 2018
DESCRIPTION:Following on from the hugely successful and long-running E&L Europe and E&L USA events\, Smithers Rapra are now extending the popular conference series into China. The inaugural event will take place in Beijing on 11-12 September 2018. \nWith extractables and leachables growing in importance in China\, understanding the regulatory landscape\, testing methods\, guidelines and best practices for carrying out E&L studies is extremely important to ensure consumer safety and eliminate risk. That’s why this conference is truly unmissable for anyone in this sector. \nAs China’s first two-day conference dedicated solely to extractables and leachables\, E&L China will equip those currently working within or planning to work within this evolving market with the information they need to succeed. Local stakeholders and renowned experts will come together for two days of training\, learning and networking. \nSmithers Rapra has been organising the European and North American editions of this conference series for over 10 years\, and has a long history of providing E&L testing so you can be sure that this conference will provide you with the most up-to-date and relevant information\, as well as a productive and valuable conference experience. \nWhatever your level or position\, Extractables and Leachables China is the place you need to be this September\, so mark your calendar and book your ticket now to avoid missing out!
URL:https://www.pharmajournalist.com/event/extractables-leachables-china-2018/
LOCATION:Mercure Beijing Downtown
ORGANIZER;CN="Smithers Rapra":MAILTO:enewton@smithers.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180910
DTEND;VALUE=DATE:20180913
DTSTAMP:20260515T035107
CREATED:20180522T100056Z
LAST-MODIFIED:20180522T100056Z
UID:15911-1536537600-1536796799@www.pharmajournalist.com
SUMMARY:The Microbiome Movement – Skin Health & Dermatology Summit
DESCRIPTION:As scientific publications and investment into skin microbiome R&D intensify\, there are still fundamental bottlenecks in truly understanding the underlying biology of host-microbiome interactions\, standardization of basic research and effective product development. \n\nThe Microbiome Movement – Skin Health & Dermatology will unite over 100 KOL’s\, senior drug developers\, cosmetic product developers & technology experts to harness the skin microbiome and accelerate the discovery\, development & commercialization of dermatological therapeutics and the next-generation of cosmetics\, founded on clinically validated data. \nJoin key decision pharma\, biotech\, cosmetic and consumer health companies to unlock the potential of the skin microbiome through sharing insight and case studies around best practice. Take a look at the event guide now to see the finalized program and meet the speakers: https://bit.ly/2Lmh0NS
URL:https://www.pharmajournalist.com/event/the-microbiome-movement-skin-health-dermatology-summit/
LOCATION:The Sheraton San Diego Hotel & Marina – Bay Tower\, 1380 Harbor Island Drive\, San Diego\, CA\, CA 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180910
DTEND;VALUE=DATE:20180912
DTSTAMP:20260515T035107
CREATED:20170615T090036Z
LAST-MODIFIED:20180814T115609Z
UID:2264-1536537600-1536710399@www.pharmajournalist.com
SUMMARY:World Drug Safety Congress Europe 2018
DESCRIPTION:World Drug Safety Congress Europe was the first strategic pharmacovigilance event to unite a plethora of stakeholders in drug safety\, from pharma and biotechs to regulators and patients. The event continues to lead the way in moving the sector forward and has been running for over a decade. It is world renowned for its ability to connect key stakeholders and grow the industry. \n \n\nThe event has grown over the years in tandem with the market. World Drug Safety Congress Europe is the only forum where you can discuss drug safety solutions\, meet future clients and begin new partnerships. On the back of our successful European show\, we brought the event to the States in 2008 and will hold our 10th Americas meeting in Philadelphia next year. \nAll our clients return year-on-year to showcase their solutions to our senior level audience. We are constantly revamping our content\, formats and topics to stay ahead of market needs which enables us to deliver the best drug safety event in the marketplace today. \nNew for this year\, we will focus on big data management in drug safety and new data sources which will help us to build on the diversity of perspectives and organisations represented. We have welcomed over 1650 senior level drug safety professionals to the event over the years. \nTo learn more about World Drug Safety Congress\, and to register online\, visit https://bit.ly/2ruzgMH \nContact\nKarina Kusova\nE: karina.kusova@terrapinn.com\nT: +442070921071
URL:https://www.pharmajournalist.com/event/world-drug-safety-congress/
LOCATION:Mövenpick Hotel\, Amsterdam
ORGANIZER;CN="Karina Kusova":MAILTO:karina.kusova@terrapinn.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180906
DTEND;VALUE=DATE:20180909
DTSTAMP:20260515T035107
CREATED:20180529T073830Z
LAST-MODIFIED:20180529T073830Z
UID:15995-1536192000-1536451199@www.pharmajournalist.com
SUMMARY:Medical Fair China 2018
DESCRIPTION:MEDICAL FAIR CHINA is a trade fair in the product family MEDICAlliance and takes place in close cooperation with the team of Düsseldorf’s leading global trade fair MEDICA. \n\nMesse Düsseldorf is committed to transferring MEDICA’s successful experience and expertise to China and integrating the latest expert perspectives\, trade opportunities and market insights into the exhibition. \nFive high caliber events staged at the same time and place will include China Medical Innovation Forum (CMIF)\, Transformation Medicine and Innovation Service Forum (TM&IS)\, Device China\, China Medical Device Design & Startup Competitions (CMDDSC)\, FTR4H Talk & Lounge and over 10 sub forums\, expecting to cover up to 20\,000 square meters. \nIn attendance will be over 400 local and international innovative medical device R&D institutions and manufacturers\, renowned innovation service providers. 5\,000 forum participants are expected amongst which are investors\, presidents and clinicians\, universities and research institutes as well as global dealers and market leaders from across the globe\, together with the visitors of Medical Fair China\, in total over 15\,000 industry peers are estimated. \nTo learn more about Medical Fair China 2018\, and to register online\, visit www.medicalfair.cn/en-us
URL:https://www.pharmajournalist.com/event/medical-fair-china-2018/
LOCATION:Suzhou International Expo Center\, 688 E. Suzhou Avenue\, Suzhou industrial Park\, Suzhou\, China
ORGANIZER;CN="Messe D%C3%BCsseldorf (Shanghai) Co.%2C Ltd.   +  China Service Alliance of Medical Device Innovation (CSAMDI)":MAILTO:Julian.Yang@MDS.CN
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180905
DTEND;VALUE=DATE:20180907
DTSTAMP:20260515T035107
CREATED:20180606T181913Z
LAST-MODIFIED:20180606T182150Z
UID:16134-1536105600-1536278399@www.pharmajournalist.com
SUMMARY:LogiPharma
DESCRIPTION:LogiPharma – Supply Chain. Optimized.\nSeptember 5-6\, 2018\nHilton Penn’s Landing\, Philadelphia\, PA \n\nLogiPharma (September 5-6\, 2018 Hilton Penn’s Landing\, Philadelphia\, PA) is a senior-level conference for supply chain VPs and Directors from leading biotechs and pharmaceutical manufacturers. We’re the only end-to-end global supply chain event designed to help you strengthen operations in an informative and interactive setting. Learn how to better serve your customers through complete supply chain visibility and minimize costs in a dynamic healthcare environment at LogiPharma. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2GHGsKl
URL:https://www.pharmajournalist.com/event/logipharma-2018/
LOCATION:Hilton Penn’s Landing\, 201 South Columbus Blvd
\, Philadelphia\, PA\, 19106\, United States
ORGANIZER;CN="Worldwide Business Research":MAILTO:Malcolm.Clark@wbresearch.com
END:VEVENT
END:VCALENDAR